Background: The risk of the acute respiratory distress syndrome (ARDS) is increased in passive and active smokers after blunt trauma. However, the mechanisms responsible, including the role of platelet aggregation, for this association are unknown. Methods: We analyzed 215 patients with severe blunt trauma from a prospective observational cohort at a Level 1 trauma center between 2010 - 2015. Subjects underwent impedance-based platelet aggregometry in response to platelet agonists arachidonic acid (ASPI), adenosine diphosphate (ADP), collagen (COL) and thrombin receptor activating peptide-6 (TRAP). ARDS within the first 8 days of admission was adjudicated using Berlin criteria. Plasma cotinine was measured to assess cigarette smoke exposure. Regression analyses were used to assess the relationship between 1) platelet aggregation and ARDS and 2) cigarette smoke exposure and platelet aggregation. Results: At both 0 and 24 hours, impaired platelet aggregation was associated with increased odds of developing ARDS. Cigarette smoke exposure was associated with increased platelet aggregation upon arrival to the emergency department. However, at 24 hours, cigarette smoke exposure was associated with increased impairment in platelet aggregation, reflecting a statistically significant decline in platelet aggregation over the initial 24 hours following trauma. The relationship between this decline in platelet aggregation and ARDS differed by cigarette smoke exposure status, suggesting that impaired platelet activation differentially affects the risk of ARDS in those with cigarette smoke exposure (ASPI, p for interaction: 0.005, COL p for interaction: 0.02, ADP, p for interaction: 0.05). Conclusions: Impaired platelet aggregation at 0 and 24 hours is associated with an increased risk of developing ARDS after severe blunt trauma. Cigarette smoke exposed patients are more likely to develop impaired platelet aggregation over the first 24 hours of admission, which may contribute to their increased risk of ARDS. Level of Evidence: Prognostic/Epidemiological, Level III (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2APjBdM
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
[PDF] Καρκίνος του στομάχου -- Αλέξανδρος Γ. Σφακιανάκης Αναπαύσεως 5 Άγιος Νικόλαος Λασιθίου 72100 2841026182
-
Abstract Introduction In recent years, platelet-rich plasma (PRP) has emerged as a promising autologous biological treatment modality fo...
-
European Journal of Trauma and Emergency Surgery from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2mFdvGj
-
Abstract Objectives To investigate the effective serum level of etanercept biosimilar in Chinese patients with ankylosing spondylitis (A...
-
Using the Pulsara app, a Cincinnati-area health care system significantly cut down its time to treatment for cardiac cases from EMS via xl...
-
Objectives: The aim of this study was to evaluate the evolution of the citation of articles from the European Journal of Emergency Medicine ...
-
from EMS via xlomafota13 on Inoreader http://ift.tt/1QHlUDw
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader http://bit.ly/2SljgLr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου